Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase III multicentre double blind randomised trial of celecoxib versus placebo following chemotherapy in primary breast cancer patients.

Trial Profile

A phase III multicentre double blind randomised trial of celecoxib versus placebo following chemotherapy in primary breast cancer patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 22 May 2018

At a glance

  • Drugs Celecoxib (Primary)
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Acronyms REACT
  • Most Recent Events

    • 09 Dec 2017 Results assessing safety and efficacy presented at the 40th Annual San Antonio Breast Cancer Symposium
    • 02 Mar 2016 Status changed from active, no longer recruiting to completed as per ISRCTN: Current Controlled Trials record.
    • 07 Nov 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top